Triheptanoin-A medium chain triglyceride with odd chain fatty acids: A new anaplerotic anticonvulsant treatment?

Epilepsy Research

Volumn 100, Issue 3, 2012, Pages 239-244

  Borges, Karin ^a   Sonnewald, Ursula ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Anaplerosis; Diet; Energy metabolism; Epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; HEPTANOIC ACID DERIVATIVE; PHENYTOIN; PILOCARPINE; PROPIONYL COENZYME A CARBOXYLASE; TRICARBOXYLIC ACID; TRIHEPTANOIN; UNCLASSIFIED DRUG; VALPROIC ACID;

ANAPLEROSIS; ANTICONVULSANT ACTIVITY; ARTICLE; DIET THERAPY; DIETARY INTAKE; DRUG MECHANISM; ENZYME INHIBITION; EPILEPSY; HUMAN; KETOGENIC DIET; NONHUMAN; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL; SEIZURE; THERAPY;

ACYL COENZYME A; ANIMALS; ANTICONVULSANTS; EPILEPSY; FATTY ACIDS; HUMANS; TRIGLYCERIDES;

EID: 84864090873     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.05.023     Document Type: Article

References (56)

1. Alvestad S., Hammer J., Eyjolfsson E., Qu H., Ottersen O.P., Sonnewald U. Limbic structures show altered glial-neuronal metabolism in the chronic phase of kainate induced epilepsy. Neurochem. Res. 2008, 33:257-266.
2. Bak L.K., Iversen P., Sorensen M., Keiding S., Vilstrup H., Ott P., Waagepetersen H.S., Schousboe A. Metabolic fate of isoleucine in a rat model of hepatic encephalopathy and in cultured neural cells exposed to ammonia. Metab. Brain Dis. 2009, 24:135-145.
3. Ballhausen D., Mittaz L., Boulat O., Bonafe L., Braissant O. Evidence for catabolic pathway of propionate metabolism in CNS: expression pattern of methylmalonyl-CoA mutase and propionyl-CoA carboxylase alpha-subunit in developing and adult rat brain. Neuroscience 2009, 164:578-587.
4. Barton M.E., Klein B.D., Wolf H.H., White H.S. Pharmacological characterization of the 6Hz psychomotor seizure model of partial epilepsy. Epilepsy Res. 2001, 47:217-227.
5. Blanco M.M., dos Santos J.G., Perez-Mendes P., Kohek S.R., Cavarsan C.F., Hummel M., Albuquerque C., Mello L.E. Assessment of seizure susceptibility in pilocarpine epileptic and nonepileptic Wistar rats and of seizure reinduction with pentylenetetrazole and electroshock models. Epilepsia 2009, 50:824-831.
6. Borges K. Mouse models: the ketogenic diet and polyunsaturated fatty acids. Epilepsia 2008, 8(Suppl. 49):64-66.
7. Bough K.J., Wetherington J., Hassel B., Pare J.F., Gawryluk J.W., Greene J.G., Shaw R., Smith Y., Geiger J.D., Dingledine R.J. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann. Neurol. 2006, 60:223-235.
8. Brandt C., Heile A., Potschka H., Stoehr T., Löscher W. Effects of the novel antiepileptic drug lacosamide on the development of amygdala kindling in rats. Epilepsia 2006, 47:1803-1809.
9. Brunengraber H., Roe C.R. Anaplerotic molecules: current and future. J. Inherit. Metab. Dis. 2006, 29:327-331.
10. Cesar M., Hamprecht B. Immunocytochemical examination of neural rat and mouse primary cultures using monoclonal antibodies raised against pyruvate carboxylase. J. Neurochem. 1995, 64:2312-2318.
11. de Almeida Rabello Oliveira M., da Rocha Ataide T., de Oliveira S.L., de Melo Lucena A.L., de Lira C.E., Soares A.A., de Almeida C.B., Ximenes-da-Silva A. Effects of short-term and long-term treatment with medium- and long-chain triglycerides ketogenic diet on cortical spreading depression in young rats. Neurosci. Lett. 2008, 434:66-70.
12. Deng S., Zhang G.F., Kasumov T., Roe C.R., Brunengraber H. Interrelations between C4 ketogenesis, C5 ketogenesis, and anaplerosis in the perfused rat liver. J. Biol. Chem. 2009, 284:27799-27807.
13. DeVivo D.C., Leckie M.P., Ferrendelli J.S., McDougal D.B. Chronic ketosis and cerebral metabolism. Ann. Neurol. 1978, 3:331-337.
14. Garriga-Canut M., Schoenike B., Qazi R., Bergendahl K., Daley T.J., Pfender R.M., Morrison J.F., Ockuly J., Stafstrom C., Sutula T., Roopra A. 2-Deoxy-d-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat. Neurosci. 2006, 9:1382-1387.
15. Gu L., Zhang G.F., Kombu R.S., Allen F., Kutz G., Brewer W.U., Roe C.R., Brunengraber H. Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats. II. Effects on lipolysis, glucose production, and liver acyl-CoA profile. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E362-E371.
16. Haberlandt E., Canestrini C., Brunner-Krainz M., Moslinger D., Mussner K., Plecko B., Scholl-Burgi S., Sperl W., Rostasy K., Karall D. Epilepsy in patients with propionic acidemia. Neuropediatrics 2009, 40:120-125.
17. Hartman A.L., Gasior M., Vining E.P., Rogawski M.A. The neuropharmacology of the ketogenic diet. Pediatr. Neurol. 2007, 36:281-292.
18. Hartman A.L., Lyle M., Rogawski M.A., Gasior M. Efficacy of the ketogenic diet in the 6Hz seizure test. Epilepsia 2008, 49:334-339.
19. Kinman R.P., Kasumov T., Jobbins K.A., Thomas K.R., Adams J.E., Brunengraber L.N., Kutz G., Brewer W.U., Roe C.R., Brunengraber H. Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats. Am. J. Physiol. Endocrinol. 2006, 291:E860-E866.
20. Klitgaard H., Matagne A., Gobert J., Wulfert E. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur. J. Pharmacol. 1998, 353:191-206.
21. Kornberg H.L. Anaplerotic sequences and their role in metabolism. Essays Biochem. 1966, 2:1-31.
22. Lamhonwah A.M., Barankiewicz T.J., Willard H.F., Mahuran D.J., Quan F., Gravel R.A. Isolation of cDNA clones coding for the alpha and beta chains of human propionyl-CoA carboxylase: chromosomal assignments and DNA polymorphisms associated with PCCA and PCCB genes. Proc. Natl. Acad. Sci. U.S.A. 1986, 83:4864-4868.
23. Leclerc J., Des Rosiers C., Montgomery J.A., Brunet J., Ste-Marie L., Reider M.W., Fernandez C.A., Powers L., David F., Brunengraber H. Metabolism of R-beta-hydroxypentanoate and of beta-ketopentanoate in conscious dogs. Am. J. Physiol. 1995, 268:E446-E452.
24. Lian X.Y., Khan F.A., Stringer J.L. Fructose-1,6-bisphosphate has anticonvulsant activity in models of acute seizures in adult rats. J. Neurosci. 2007, 27:12007-12011.
25. Lian X.Y., Xu K., Stringer J.L. Oral administration of fructose-1,6-diphosphate has anticonvulsant activity. Neurosci. Lett. 2008, 446:75-77.
26. Löscher W., Honack D., Fassbender C.P., Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs III. Pentylenetetrazole seizure models. Epilepsy Res. 1991, 8:171-189.
27. Martini W.Z., Stanley W.C., Huang H., Rosiers C.D., Hoppel C.L., Brunengraber H. Quantitative assessment of anaplerosis from propionate in pig heart in vivo. Am. J. Physiol. Endocrinol. Metab 2003, 284:E351-E356.
28. Masino S.A., Geiger J.D. Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?. Trends Neurosci. 2008, 31:273-278.
29. Masino S.A., Kawamura M., Wasser C.A., Pomeroy L.T., Ruskin D.N. Adenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activity. Curr. Neuropharmacol. 2009, 7:257-268.
30. Matagne A., Klitgaard H. Validation of corneally kindled mice: a sensitive screening model for partial epilepsy in man. Epilepsy Res. 1998, 31:59-71.
31. Matagne A., Margineanu D.G., Kenda B., Michel P., Klitgaard H. Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A. Br. J. Pharmacol. 2008, 154:1662-1671.
32. Melo T.M., Nehlig A., Sonnewald U. Metabolism is normal in astrocytes in chronically epileptic rats: a (13)C NMR study of neuronal-glial interactions in a model of temporal lobe epilepsy. J. Cereb. Blood Flow Metab. 2005, 25:1254-1264.
33. Mochel F., DeLonlay P., Touati G., Brunengraber H., Kinman R.P., Rabier D., Roe C.R., Saudubray J.M. Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy. Mol. Genet. Metab. 2005, 84:305-312.
34. Neal E.G., Chaffe H., Schwartz R.H., Lawson M.S., Edwards N., Fitzsimmons G., Whitney A., Cross J.H. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008, 7:500-506.
35. Nguyen N.H., Morland C., Gonzalez S.V., Rise F., Storm-Mathisen J., Gundersen V., Hassel B. Propionate increases neuronal histone acetylation, but is metabolized oxidatively by glia relevance for propionic acidemia. J. Neurochem. 2007, 101:806-814.
36. Nuutinen E.M., Peuhkurinen K.J., Pietilainen E.P., Hiltunen J.K., Hassinen I.E. Elimination and replenishment of tricarboxylic acid-cycle intermediates in myocardium. Biochem. J. 1981, 194:867-875.
37. Owen O.E., Kalhan S.C., Hanson R.W. The key role of anaplerosis and cataplerosis for citric acid cycle function. J. Biol. Chem. 2002, 277:30409-30412.
38. 2-fixing enzymes in the metabolism of rat brain. J. Neurochem. 1974, 22:717-724.
39. Potschka H., Löscher W. Corneal kindling in mice: behavioral and pharmacological differences to conventional kindling. Epilepsy Res. 1999, 37:109-120.
40. Reszko A.E., Kasumov T., Pierce B.A., David F., Hoppel C.L., Stanley W.C., Des Rosiers C., Brunengraber H. Assessing the reversibility of the anaplerotic reactions of the propionyl-CoA pathway in heart and liver. J. Biol. Chem. 2003, 278:34959-34965.
41. Roe C.R., Bottiglieri T., Wallace M., Arning E., Martin A. Adult polyglucosan body disease (APBD): anaplerotic diet therapy (triheptanoin) and demonstration of defective methylation pathways. Mol. Genet. Metab. 2010, 101:246-252.
42. Roe C.R., Mochel F. Anaplerotic diet therapy in inherited metabolic disease: therapeutic potential. J. Inherit. Metab. Dis. 2006, 29:332-340.
43. Roe C.R., Sweetman L., Roe D.S., David F., Brunengraber H. Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J. Clin. Invest. 2002, 110:259-269.
44. Roe C.R., Yang B.Z., Brunengraber H., Roe D.S., Wallace M., Garritson B.K. Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy. Neurology 2008, 71:260-264.
45. Rowley N.M., White H.S. Comparative anticonvulsant efficacy in the corneal kindled mouse model of partial epilepsy: correlation with other seizure and epilepsy models. Epilepsy Res. 2010, 92:163-169.
46. Samala R., Willis S., Borges K. Anticonvulsant profile of a balanced ketogenic diet in acute mouse seizure models. Epilepsy Res. 2008, 81:119-127.
47. Shank R.P., Bennett G.S., Freytag S.O., Campbell G.L. Pyruvate carboxylase: an astrocyte-specific enzyme implicated in the replenishment of amino acid neurotransmitter pools. Brain Res. 1985, 329:364-367.
48. Silver J.M., Shin C., McNamara J.O. Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilespy. Ann. Neurol. 1991, 29:356-363.
49. Sonnewald U., Rae C. Pyruvate carboxylation in different model systems studied by (13)C MRS. Neurochem. Res. 2010, 35:1916-1921.
50. Stafstrom C.E., Ockuly J.C., Murphree L., Valley M.T., Roopra A., Sutula T.P. Anticonvulsant and antiepileptic actions of 2-deoxy-d-glucose in epilepsy models. Ann. Neurol. 2009, 65:435-447.
51. Turski W.A., Cavalheiro E.A., Bortolotto Z.A., Mello L.M., Schwarz M., Turski L. Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis. Brain Res. 1984, 321:237-253.
52. Turski W.A., Cavalheiro E.A., Schwarz M., Czuczwar S.J., Kleinrok Z., Turski L. Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav. Brain Res. 1983, 9:315-335.
53. White H.S., Woodhead J.H., Wilcox K.S., Stables J.P., Kupferberg H.J., Wolf H.H. Discovery and preclinical development of antiepileptic drugs. Antiepileptic Drugs 2002, 36-48. Lippincott Williams & Wilkins, Philadelphia. R.H. Levy, R.H. Mattson, B.S. Meldrum, E. Perucca (Eds.).
54. Willis S., Stoll J., Sweetman L., Borges K. Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models. Neurobiol. Dis. 2010, 40:565-572.
55. Thomas, N.K., Willis, S., Sweetman, L., Borges, K., submitted. Anticonvulsant profile of triheptanoin in acute mouse seizure models. Epilepsia.
56. Yu A.C., Drejer J., Hertz L., Schousboe A. Pyruvate carboxylase activity in primary cultures of astrocytes and neurons. J. Neurochem. 1983, 41:1484-1487.